You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR MIGALASTAT HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for MIGALASTAT HYDROCHLORIDE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00214500 ↗	A Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease	Completed	Amicus Therapeutics	Phase 2	2006-01-02	Study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of migalastat hydrochloride (HCl) (migalastat) in participants with Fabry disease.
NCT00283933 ↗	A 24-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease	Completed	Amicus Therapeutics	Phase 2	2006-05-09	Study to evaluate the safety, tolerability, and pharmacodynamics of migalastat hydrochloride (HCl) (migalastat) in participants with Fabry disease.
NCT00283959 ↗	A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease	Completed	Amicus Therapeutics	Phase 2	2006-06-27	Study to evaluate the safety, tolerability, and pharmacodynamics of migalastat hydrochloride (HCl) (migalastat) and how migalastat works in participants with Fabry disease.
NCT00304512 ↗	A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Female Participants With Fabry Disease	Completed	Amicus Therapeutics	Phase 2	2006-09-07	Study to evaluate the safety, tolerability, and pharmacodynamics of migalastat hydrochloride (HCl) (migalastat) in participants with Fabry disease.
NCT00526071 ↗	Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study	Terminated	Amicus Therapeutics	Phase 2	2007-09-17	Study to evaluate the long-term safety, tolerability, and pharmacodynamics (PD) of migalastat hydrochloride (HCl) (migalastat) in participants with Fabry disease
NCT00925301 ↗	Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease	Completed	Amicus Therapeutics	Phase 3	2009-10-23	The primary objective of this study was to compare the effect of migalastat (123 milligrams [mg] of migalastat [equivalent to 150 mg of migalastat hydrochloride]) (migalastat) versus placebo on kidney globotriaosylceramide (GL-3).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for MIGALASTAT HYDROCHLORIDE

Condition Name

Chart
Table

Condition Name for MIGALASTAT HYDROCHLORIDE
Intervention	Trials
Fabry Disease	19
Fabry's Disease	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for MIGALASTAT HYDROCHLORIDE
Intervention	Trials
Fabry Disease	20
Renal Insufficiency	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for MIGALASTAT HYDROCHLORIDE

Trials by Country

Map
Table

Trials by Country for MIGALASTAT HYDROCHLORIDE
Location	Trials
United States	86
Australia	18
United Kingdom	11
Canada	10
France	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for MIGALASTAT HYDROCHLORIDE
Location	Trials
Georgia	11
New York	8
Virginia	7
Pennsylvania	7
Texas	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for MIGALASTAT HYDROCHLORIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for MIGALASTAT HYDROCHLORIDE
Clinical Trial Phase	Trials
Phase 3	8
Phase 2	6
Phase 1	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for MIGALASTAT HYDROCHLORIDE
Clinical Trial Phase	Trials
Completed	14
Not yet recruiting	2
Terminated	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MIGALASTAT HYDROCHLORIDE

Sponsor Name

Chart
Table

Sponsor Name for MIGALASTAT HYDROCHLORIDE
Sponsor	Trials
Amicus Therapeutics	19
Genzyme, a Sanofi Company	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for MIGALASTAT HYDROCHLORIDE
Sponsor	Trials
Industry	20
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.